An ultralow dose of...
 
Notifications
Clear all

An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer

2 Posts
2 Users
4 Reactions
532 Views
(@j)
Joined: 6 years ago
Posts: 2166
Topic starter  

"The present study revealed that an ultralow dose of DPI, with no significant systemic toxicity involved, may be an effective way to prevent the occurrence and development of CAC"

https://www.thno.org/v10p6743.htm


   
Daniel and Daniel reacted
Quote
(@daniel)
Admin
Joined: 9 years ago
Posts: 1194
 

Thank you Johan! Very helpful one!

And nice to see your real picture in your profile πŸ™‚ https://www.cancertreatmentsresearch.com/community/profile/johan/


   
johan and johan reacted
ReplyQuote
Share: